LB Pharmaceuticals (LBRX) announced the appointment of James Rawls, Pharm.D., as Senior Vice President, SVP, of Regulatory Affairs. Rawls joins LB Pharmaceuticals from Boston Biodevelopment, where he served as Executive Vice President and Chief Regulatory Officer
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LBRX:
- Opening Day: Cerebras Systems withdraws IPO filing
- Buy Rating for LB Pharmaceuticals Driven by Promising LB-102 and Market Potential
- LB Pharmaceuticals to present posters on Phase 2 NOVA trial of LB-102
- LB Pharmaceuticals initiated with an Outperform at Leerink
- LB Pharmaceuticals initiated with a Buy at Stifel